2-140274598-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_018557.3(LRP1B):āc.12968A>Gā(p.Tyr4323Cys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000728 in 1,606,244 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000053 ( 0 hom., cov: 33)
Exomes š: 0.000075 ( 0 hom. )
Consequence
LRP1B
NM_018557.3 missense, splice_region
NM_018557.3 missense, splice_region
Scores
1
11
7
Splicing: ADA: 0.03493
2
Clinical Significance
Conservation
PhyloP100: 6.17
Genes affected
LRP1B (HGNC:6693): (LDL receptor related protein 1B) This gene encodes a member of the low density lipoprotein (LDL) receptor family. These receptors play a wide variety of roles in normal cell function and development due to their interactions with multiple ligands. Disruption of this gene has been reported in several types of cancer. [provided by RefSeq, Jun 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 8 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRP1B | NM_018557.3 | c.12968A>G | p.Tyr4323Cys | missense_variant, splice_region_variant | 85/91 | ENST00000389484.8 | |
LRP1B | XM_017004341.2 | c.12578A>G | p.Tyr4193Cys | missense_variant, splice_region_variant | 85/91 | ||
LRP1B | XM_017004342.1 | c.7820A>G | p.Tyr2607Cys | missense_variant, splice_region_variant | 56/62 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRP1B | ENST00000389484.8 | c.12968A>G | p.Tyr4323Cys | missense_variant, splice_region_variant | 85/91 | 1 | NM_018557.3 | P1 | |
LRP1B | ENST00000437977.5 | c.1664A>G | p.Tyr555Cys | missense_variant, splice_region_variant | 12/17 | 5 | |||
LRP1B | ENST00000442974.1 | c.164A>G | p.Tyr55Cys | missense_variant, splice_region_variant | 2/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151904Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
8
AN:
151904
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000204 AC: 5AN: 245416Hom.: 0 AF XY: 0.0000226 AC XY: 3AN XY: 132684
GnomAD3 exomes
AF:
AC:
5
AN:
245416
Hom.:
AF XY:
AC XY:
3
AN XY:
132684
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000749 AC: 109AN: 1454340Hom.: 0 Cov.: 32 AF XY: 0.0000761 AC XY: 55AN XY: 723202
GnomAD4 exome
AF:
AC:
109
AN:
1454340
Hom.:
Cov.:
32
AF XY:
AC XY:
55
AN XY:
723202
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000527 AC: 8AN: 151904Hom.: 0 Cov.: 33 AF XY: 0.0000539 AC XY: 4AN XY: 74144
GnomAD4 genome
AF:
AC:
8
AN:
151904
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74144
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2023 | The c.12968A>G (p.Y4323C) alteration is located in exon 85 (coding exon 85) of the LRP1B gene. This alteration results from a A to G substitution at nucleotide position 12968, causing the tyrosine (Y) at amino acid position 4323 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D
MetaSVM
Uncertain
T
MutationAssessor
Benign
L
MutationTaster
Benign
D
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Benign
T
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at